m-RESIST “An innovative disease management system based on mobile technologies” m-Resist research project aims to empower patients with treatment-resistant schizophrenia to better self-manage their condition. Its goal is to examine how mHealth techniques can help in early intervention and treatment of schizophrenia, by promoting collaboration between patients, caregivers, and clinicians. The Solution The m-Resist platform consists of specific intervention modules specially designed for patients with treatment-resistant schizophrenia. Who can use m-Resist m-Resist is designed to be used by patients, caregivers and clinicians. The protocol within m-Resist project, encourages patients with Treatment-Resistant Schizophrenia to engage in their health care, helps caregivers play a more active role in the treatment, and provides clinicians with a remote monitoring tool to make clinical decisions. The benefits of m-Resist • Improves the communication between patients, caregivers, and clinicians • Includes a complete assessment of personal and clinical variables • Defines targeted interventions that mitigate the severity of worsening • Continuously captures multidimensional behavior in real-time in real-world environments • Detects individual Early Warning Signs and offers personalized recommendations Partners Involved This project is co-funded by the Horizon 2020 Framework Programme of the European Union under grant agreement no [643552] Follow-mresist: • www.mresist.eu Twitter: mResist_eu